| | Call Details | Conceptus Earnings Conference Call (Q3 2009) Wed,
Oct 21, 2009, 4:30 pm Eastern
| | About Conceptus
(NasdaqGM:CPTS) |
| | Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications in the United States. The company offers Essure, a permanent birth control system for women. The Essure system uses a micro-insert that is delivered into a woman's fallopian tubes to provide permanent birth control by causing a benign tissue in-growth that blocks the fallopian tubes. The company distributes its products through direct sales force and distributor networks, as well as media, including television, radio, direct mail, and print to gynecologists and general practitioners. Conceptus, Inc. was founded in 1992 and is headquartered in Mountain View, California. |
| More
Info:
Quote
|
Chart
|
News
|
Profile
|
Reports
|
Research
|
SEC
|
Msgs
|
Insider
|
Analyst Ratings |
|